|
ZBTB10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83760000549427E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.66430002901797E-09 |
| Normal-vs-Stage2 |
5.012200E-04 |
| Normal-vs-Stage3 |
3.201800E-04 |
| Normal-vs-Stage4 |
4.670500E-02 |
| Stage1-vs-Stage2 |
4.381600E-01 |
| Stage1-vs-Stage3 |
2.140000E-01 |
| Stage1-vs-Stage4 |
4.325800E-01 |
| Stage2-vs-Stage3 |
7.858200E-01 |
| Stage2-vs-Stage4 |
6.515400E-01 |
| Stage3-vs-Stage4 |
8.036000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95619999976415E-07 |
| Normal-vs-AfricanAmerican |
6.85309999859385E-08 |
| Normal-vs-Asian |
9.702700E-03 |
| Caucasian-vs-AfricanAmerican |
4.811600E-01 |
| Caucasian-vs-Asian |
7.908000E-01 |
| AfricanAmerican-vs-Asian |
9.772400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98020044805958E-10 |
| Normal-vs-Female |
1.197540E-03 |
| Male-vs-Female |
1.392480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.14039999998816E-06 |
| Normal-vs-Extreme_Weight |
1.03460000011601E-07 |
| Normal-vs-Obese |
1.629110E-04 |
| Normal-vs-Extreme_Obese |
1.763860E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.816200E-01 |
| Normal_Weight-vs-Obese |
1.359370E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.469200E-01 |
| Extreme_Weight-vs-Obese |
6.298400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.239800E-01 |
| Obese-vs-Extreme_Obese |
1.804580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.605600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.63132999999593E-05 |
| Normal-vs-Age(61-80Yrs) |
9.93849447183948E-11 |
| Normal-vs-Age(81-100Yrs) |
2.31299999999823E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.965600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.974400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.584180E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.147900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.177800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.223200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.33580000394318E-08 |
| Normal-VS-Type2 PRCC |
4.35460000280941E-08 |
| Normal-VS-KIRP CIMP |
7.974800E-01 |
| Normal-VS-Unclassified PRCC |
1.952770E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.117000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.773900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.561800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.393900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.077500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.110200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32769994998228E-09 |
| Normal-vs-N1 |
2.497900E-02 |
| Normal-vs-N2 |
8.083800E-01 |
| N0-vs-N1 |
1.233590E-02 |
| N0-vs-N2 |
3.907200E-01 |
| N1-vs-N2 |
5.887800E-01 |
|
|
